FDA Establishes Advisory Committee for Digital Health Technology

News
Article

The application deadline to serve on the committee is Dec. 11.

Troy Tazbaz, Director of Digital Health at Food & Drug Administration

Troy Tazbaz, Director of Digital Health at Food & Drug Administration

The FDA announced in October the creation of a digital health advisory committee which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.

“Technology moves at an incredible pace, and we’re excited to have a committee of experts throughout the field who can help ensure our regulation of these exciting tools maintains an appropriate pace while working within parameters of safety and effectiveness standards,” Troy Tazbaz, director of the FDA’s Digital Health Center of Excellence said in a news release.

The committee is expected to be fully operational in 2024. It will consist of nine voting members, including the chair. The agency seeks individuals with diverse scientific and technical experience.

The FDA is accepting applications until Dec. 11. The application can be found on the FDA Advisory Committee Membership Nomination Portal.

Recent Videos
Jill Zouzoulas, MD, FACR, an expert on biologic therapies
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 5 - "Obstacles in Adapting Diabetes Technology to Individual Needs" - 1 KOL is featured
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 4 - "The Impact of Continuous Glucose Monitors & Digital Solutions on Diabetes Care"
Video 3 - "The Pivotal Role of Patient Engagement and Education in Achieving Optimal Diabetes Outcomes"
Related Content
© 2024 MJH Life Sciences

All rights reserved.